By KATIE THOMAS
A lawsuit claimed that Cephalon, a subsidiary of Teva Pharmaceuticals, had paid generic manufacturers to keep a cheaper version of a drug off the market.
Published: April 21, 2015 at 12:00PM
from NYT Business Day http://ift.tt/1J4wxgq
via IFTTT
Read more...
No comments:
Post a Comment